Integrative bioinformatics analysis identifies HCCS as a prognostic and therapeutic biomarker in lung cancer.
Saved in:
| Title: | Integrative bioinformatics analysis identifies HCCS as a prognostic and therapeutic biomarker in lung cancer. |
|---|---|
| Authors: | Bellah SF; Department of Pharmacy, Pabna University of Science and Technology, Pabna, Bangladesh., Hossen MA; Department of Physical Sciences, Independent University, Bangladesh, Dhaka, Bangladesh.; Bioinformatics Laboratory, Department of Statistics, University of Rajshahi, Rajshahi, Bangladesh., Billah SMS; Department of Chemistry, National University, Gazipur, Bangladesh. |
| Source: | Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2026 Jan-Dec; Vol. 43, pp. 18758592261429264. Date of Electronic Publication: 2026 Mar 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: IOS Press Country of Publication: United States NLM ID: 101256509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1875-8592 (Electronic) Linking ISSN: 15740153 NLM ISO Abbreviation: Cancer Biomark Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
